Back

Patients with pulmonary embolism and cardiogenic shock benefit from interventional therapy rather than conventional thrombolytic therapy. A case analysis of all inpatients in Germany 2022 and 2025

29 August 2026 (08:39 - 08:51)
Organised by: Logo
Congress Presentation Part of: Acute pulmonary embolism: risk and interventional therapies Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Stefan Andreas Lange

University Hospital of Munster, Munster (Germany)

4 More presentations in this session

Presentation thumbnail
Activated factor XI is associated with recurrent venous thromboembolism in patients following pulmonary embolism: a cohort study
Mr P. Michel (Krakow, PL)
Abstract Slides
Presentation thumbnail
High-risk pe patients eligible for both large-bore mechanical thrombectomy and systemic thrombolysis: insights from the FLASH and FLAME Studies
Doctor L. Hobohm (Mainz, DE)
Abstract Slides
Presentation thumbnail
Early respiratory–metabolic phenotypes predict 48-hour hemodynamic deterioration in intermediate-high risk pulmonary embolism
Doctor M. Zuin (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Catheter-directed therapy in intermediate-high risk pulmonary embolism: which predictive factors for a favorable therapy response?
Doctor E. Blachere (Montpellier, FR)
Abstract Slides

Access the full session

Session thumbnail
Acute pulmonary embolism: risk and interventional therapies
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:39 CET
You may be interested in
thumbnail
Congress Presentation
Results of systemic fibrinolysis vs. ECMO VA in patients with profound shock (SCAI D-E) due to acute pulmonary embolism
20 March 2026
thumbnail
Congress Presentation
Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study.
3 September 2019
thumbnail
Congress Presentation
Complications and time trends of ballon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
20 March 2026
thumbnail
Congress Presentation
Predictors of mortality in patients with intermediate risk pulmonary embolism
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources